Matinas BioPharma Holdings, Inc. (MTNB) Insider Trading Activity

AMEX$1.16+0.02 (1.75%)
Market Cap
$486,870.00
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
664 of 849
Rank in Industry
379 of 491

MTNB Insider Trading Activity

MTNB Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its primary experimental drug, LYPDISO, is a …

Insider Activity of Matinas BioPharma Holdings, Inc.

Over the last 12 months, insiders at Matinas BioPharma Holdings, Inc. have bought $0 and sold $0 worth of Matinas BioPharma Holdings, Inc. stock.

On average, over the past 5 years, insiders at Matinas BioPharma Holdings, Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $16,600 was made by STERN ADAM K (director) on 2020‑08‑21.

List of Insider Buy and Sell Transactions, Matinas BioPharma Holdings, Inc.

2020-08-21PurchaseSTERN ADAM Kdirector
20,000
0.01%
$0.83
$16,600
+3.36%
2020-05-14PurchaseLEPORE PATRICK Gdirector
100,000
0.0504%
$0.73
$73,050
+20.81%
2020-03-17PurchaseJabbour Jerome DPresident and CEO
10,000
0.0051%
$0.65
$6,500
+25.71%
2020-03-17PurchaseSTERN ADAM Kdirector
10,000
0.0051%
$0.65
$6,500
+25.71%
2019-11-25PurchaseKucinski Keith AChief Financial Officer
58,000
0.0387%
$1.23
$71,160
-26.55%
2019-11-22PurchaseKucinski Keith AChief Financial Officer
36,500
0.0234%
$1.20
$43,807
-27.98%
2019-11-15PurchaseLEPORE PATRICK Gdirector
100,000
0.0623%
$1.06
$105,530
-19.25%
2019-08-20PurchaseEnde Eric Jdirector
20,000
0.0126%
$0.66
$13,200
+23.73%
2019-08-19PurchaseSTERN ADAM Kdirector
10,400
0.0068%
$0.70
$7,268
+20.39%
2019-08-19PurchaseJabbour Jerome DPresident and CEO
14,650
0.0093%
$0.68
$9,975
+20.39%
2019-08-19PurchaseEnde Eric Jdirector
20,000
0.0127%
$0.68
$13,650
+20.39%
2019-08-16PurchaseLEPORE PATRICK Gdirector
100,000
0.0655%
$0.72
$71,850
+17.95%
2019-06-14PurchaseSTERN ADAM Kdirector
15,000
0.0105%
$0.80
$12,000
+3.27%
2019-06-12PurchaseSTERN ADAM Kdirector
20,000
0.0141%
$0.80
$15,998
+4.19%
2019-06-12PurchaseJabbour Jerome DPresident and CEO
12,487
0.0088%
$0.80
$9,980
+4.19%
2019-06-10PurchaseSTERN ADAM Kdirector
15,000
0.0103%
$0.82
$12,300
-0.91%
2019-06-07PurchaseSTERN ADAM Kdirector
20,000
0.0146%
$0.89
$17,800
-2.82%
2019-05-31PurchaseSTERN ADAM Kdirector
80,000
0.0547%
$0.94
$75,200
-13.96%
2019-05-16PurchaseSTERN ADAM Kdirector
150,000
0.1064%
$0.95
$142,500
-11.51%
2019-05-16PurchaseCONRAD HERBERT Jdirector
25,000
0.018%
$0.96
$24,115
-11.51%
Total: 30

Insider Historical Profitability

8.72%
Rongen RoelofChief Executive Officer
3539416
828.7498%
$4.03M10
STERN ADAM Kdirector
3301983
773.1552%
$3.76M120
+16.49%
MANNINO RAPHAEL JChief Scientific Officer
1424565
333.5601%
$1.62M10
Jabbour Jerome DPresident and CEO
799511
187.2045%
$911,442.5430
+23.05%
Scibetta James Sdirector
418309
97.9465%
$476,872.2610
LEPORE PATRICK Gdirector
400000
93.6595%
$456,000.0040
+6.5%
FERRARI STEFANOdirector
203984
47.7626%
$232,541.7610
CONRAD HERBERT Jdirector
172959
40.4981%
$197,173.2630
Ende Eric Jdirector
109292
25.5906%
$124,592.8820
+22.06%
Kucinski Keith AChief Financial Officer
94500
22.1271%
$107,730.0020
<0.0001%

Historical Insider Profitability vs. Competitors

$6,974,678
45
-14.98%
$4.63M
$633,070
27
-5.89%
$2.04M
$8,249,886
17
-47.87%
$399,787.00
$117,515
16
-27.38%
$1.66M
$1,246,170
12
65.67%
$5.42M

MTNB Institutional Investors: Active Positions

Increased Positions12+37.5%184,146+55.78%
Decreased Positions8-25%71,763-21.74%
New Positions8New181,612New
Sold Out Positions6Sold Out47,703Sold Out
Total Postitions36+12.5%442,491+34.04%

MTNB Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$37.001%59,72500%2025-09-30
Geode Capital Management, Llc$35.000.93%55,970+476+0.86%2025-09-30
Blackrock, Inc.$31.000.83%49,65000%2025-09-30
Sargent Investment Group, Llc$23.000.61%36,620+1,000+2.81%2025-09-30
Holos Integrated Wealth Llc$20.000.54%32,48000%2025-06-30
Renaissance Technologies Llc$18.000.47%28,270+3,600+14.59%2025-09-30
Northern Trust Corp$14.000.38%22,594+22,594New2025-09-30
State Street Corp$10.000.26%15,32200%2025-09-30
Two Sigma Securities, Llc$8.000.21%12,560+12,560New2025-09-30
Hrt Financial Lp$7.000.18%10,784+10,784New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.